Clinical trial
A Randomized, Double-Blind Study Comparing Safety and Tolerability of Perlane® With and Without Addition of 0.3% Lidocaine HCL During Correction of Nasolabial Folds
NCT00823069 is registered in ClinicalTrials.gov with Medicis Global Service Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind Study Comparing Safety and Tolerability of Perlane® With and Without Addition of 0.3% Lidocaine HCL During Correction of Nasolabial Folds
- Lead sponsor
- Medicis Global Service Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- April 30, 2009
- Enrollment
- 60 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
nasolabial folds